IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 49 filers reported holding IBERE PHARMACEUTICALS in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,257,000 | +1.1% | 227,718 | +0.0% | 0.00% | 0.0% |
| Q2 2022 | $2,233,000 | -70.7% | 227,698 | -70.7% | 0.00% | -50.0% |
| Q1 2022 | $7,629,000 | +1.0% | 777,698 | +0.1% | 0.00% | 0.0% |
| Q4 2021 | $7,551,000 | +0.3% | 776,834 | -0.0% | 0.00% | 0.0% |
| Q3 2021 | $7,528,000 | +41.5% | 776,839 | +41.2% | 0.00% | +100.0% |
| Q2 2021 | $5,320,000 | – | 550,097 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ampfield Management, L.P. | 44,542 | $432,000 | 0.38% |
| BASSO CAPITAL MANAGEMENT, L.P. | 170,114 | $1,648,000 | 0.19% |
| SPRING CREEK CAPITAL LLC | 400,000 | $3,876,000 | 0.19% |
| MANGROVE PARTNERS IM, LLC | 200,000 | $1,938,000 | 0.17% |
| DARK FOREST CAPITAL MANAGEMENT LP | 44,713 | $433,000 | 0.15% |
| ROBINSON CAPITAL MANAGEMENT, LLC | 16,533 | $160,000 | 0.14% |
| Vestcor Inc | 400,000 | $3,876,000 | 0.14% |
| Castle Creek Arbitrage, LLC | 253,446 | $2,455,000 | 0.14% |
| KNOTT DAVID M | 36,000 | $349,000 | 0.13% |
| Radcliffe Capital Management, L.P. | 300,000 | $2,907,000 | 0.08% |